Possible role of REG lα protein in ulcerative colitis and colitic cancer

Sekikawa, A.; Fukui, H.; Fujii, S.; Nanakin, A.; Kanda, N.; Uenoyoma, Y.; Sawabu, T.; Hisatsune, H.; Kusaka, T.; Ueno, S.; Nakase, H.; Seno, H.; Fujimori, T.; Chiba, T.
October 2005
Gut;Oct2005, Vol. 54 Issue 10, p1437
Academic Journal
Background and aims: Although regenerating gene (REG) lα protein may be involved in the inflammation and carcinogenesis in the gastrointestinal tract, its pathophysiological role in ulcerative colitis (UC) and the resulting colitic cancer remains unclear. We investigated expression of the REG lα gene and its protein in UC and colitic cancer tissues. We examined whether cytokines are responsible for REG lα gene expression and whether REG lot protein has a trophic and/or an antiapoptotic effect on colon cancer cells. Methods: Expression of REG In mRNA and its gene product in UC tissues was analysed by real time reverse transcription-polymerase chain reaction and immunohistochemistry, respectively. The effects of cytokines on REG lα promoter activity were examined in LoVo cells by luciferase reporter assay. The effects of REG lot protein on growth and H2O2 induced apoptosis were examined in LoVo cells by MU and TUNEL assays, respectively. Results: REG lα protein was strongly expressed in inflamed epithelium and in dysplasias and cancerous lesions in UC tissues. The level of REG lα mRNA expression in UC tissues correlated significantly with severity of inflammation and disease duration. REG let promoter activity was enhanced by stimulation with interferon γ or interleukin 6. REG lα protein promoted cell growth and conferred resistance to H2O2 induced apoptosis in LoVo cells. REG lα protein promoted Akt phosphorylation and enhanced Bcl-xL and Bcl-2 expression in LoVo cells. Conclusions: The REG lαgene is inducible by cytokines and its gene product may function as a mitogenic and/or an antiapoptotic factor in the UC-colitic cancer sequence.


Related Articles

  • Suppression of Ulcerative Colitis in Mice by Orally Available Inhibitors of Sphingosine Kinase. Lynn Maines; Leo Fitzpatrick; Kevin French; Yan Zhuang; Zuping Xia; Staci Keller; John Upson // Digestive Diseases & Sciences;Apr2008, Vol. 53 Issue 4, p997 

    Abstract  A critical step in the mechanism of action of inflammatory cytokines is the stimulation of sphingolipid metabolism, including activation of sphingosine kinase (SK), which produces the mitogenic and proinflammatory lipid sphingosine 1-phosphate (S1P). We have developed...

  • Synergy of IL-23 and Th17 Cytokines: New Light on Inflammatory Bowel Disease. Shen, Wei; Durum, Scott K. // Neurochemical Research;Jun2010, Vol. 35 Issue 6, p940 

    Inflammatory bowel diseases (IBDs), including Crohn’s disease and ulcerative colitis, involve an interplay between host genetics and environmental factors including intestinal microbiota. Animal models of IBD have indicated that chronic inflammation can result from over-production of...

  • Factors Predicting Postoperative Infectious Complications and Early Induction of Inflammatory Mediators in Ulcerative Colitis Patients. Miki, Chikao; Ohmori, Yukinari; Yoshiyama, Shigeyuki; Toiyama, Yuji; Araki, Toshimitsu; Uchida, Keiichi; Kusunoki, Masato // World Journal of Surgery;Mar2007, Vol. 31 Issue 3, p522 

    Positive outcomes after restorative proctocolectomy are compromised by a number of specific septic complications. However, there is no useful perioperative marker predicting postoperative infectious complications (PICs) in steroid overdosed patients with ulcerative colitis (UC). To determine...

  • Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Balding, Joanna; Livingstone, Wendy J.; Conroy, Judith; Mynett-Johnson, Lesley; Weir, Donald G.; Mahmud, Nasir; Smith, Owen P. // Mediators of Inflammation;Jun2004, Vol. 13 Issue 3, p181 

    T he mechanisms responsible for development of inflammatory bowel disease (IBD) have not been fully elucidated, although the main cause of disease pathology is attributed to up-regulated inflammatory processes. The aim of this study was to investigate frequencies of polymorphisms in genes...

  • Interfering with interferons in inflammatory bowel disease. Ghosh, S.; Chaudhary, R.; Carpani, M.; Playford, R. // Gut;Aug2006, Vol. 55 Issue 8, p1071 

    The article discusses the use of interferons for the treatment of inflammatory bowel disease. Interferons show antitumor and antiviral activities. In inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, there is an increase in plasma and tissue concentrations of...

  • Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis. Sandborn, William J.; Ghosh, Subrata; Panes, Julian; Vranic, Ivana; Su, Chinyu; Rousell, Samantha; Niezychowski, Wojciech // New England Journal of Medicine;8/16/2012, Vol. 367 Issue 7, p616 

    Background: Ulcerative colitis is a chronic inflammatory disease of the colon for which current treatments are not universally effective. One additional treatment may be tofacitinib (CP-690,550), an oral inhibitor of Janus kinases 1, 2, and 3 with in vitro functional specificity for kinases 1...

  • Disease Course and Surgery Rates in Inflammatory Bowel Disease: A Population-Based, 7-Year Follow-Up Study in the Era of Immunomodulating Therapy. Vester-Andersen, Marianne K; Prosberg, Michelle V; Jess, Tine; Andersson, Mikael; Bengtsson, Bo G; Blixt, Thomas; Munkholm, Pia; Bendtsen, Flemming; Vind, Ida // American Journal of Gastroenterology;May2014, Vol. 109 Issue 5, p705 

    Objectives:In this population-based 7-year follow-up of incident patients with ulcerative colitis (UC) or Crohn's disease (CD), we aimed to describe disease progression and surgery rates in an era influenced by the increased use of immunosuppressants and the introduction of biological...

  • The role of mucosal T lymphocytes in regulating intestinal inflammation. Uhlig, Holm; Powrie, Fiona // Springer Seminars in Immunopathology;Sep2005, Vol. 27 Issue 2, p167 

    Suppression of chronic intestinal inflammation by different subtypes of T cells has been described in recent years. In particular, naturally arising CD4+CD25+ regulatory T cells and IL-10-producing regulatory T cell type 1 CD4+ T lymphocytes have been implicated in the regulation of intestinal...

  • Serum concentration of interleukin 10, anti-mannan Candida antibodies and the fungal colonization of the gastrointestinal tract in patients with ulcerative colitis. Ksiadzyna, D.; Semianow-Wejchert, J.; Nawrot, U.; Wlodarczyk, K.; Paradowski, L. // Advances in Medical Sciences (De Gruyter Open);2009, Vol. 54 Issue 2, p170 

    Purpose: There is evidence for the immunomodulation disorders in the response to intestinal flora in inflammatory bowel disease, however, the role of yeasts in the aetiopathogenesis of ulcerative colitis has not been fully clarified. The aim of this study was to assess the serum concentration of...


Read the Article


Sign out of this library

Other Topics